[The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].
One of the main methods the treatment of patients with supraventricular paroxysmal tachycardia remains drug therapy, which involves the prevention attacks of cardiac arrhythmias. Drugs of choice for termination and prevention of paroxysmal supraventricular tachycardia in the absence of pronounced signs structural myocardial damage is an antiarrhythmic with I C class (propafenon - propanorm). Efficacy of propafenon and its influence on the functional state of heart in patients with paroxysmal antrioventricular tachycardias was studied. It was found that propafenon is highly effective in preventing paroxysmal antrioventricular reciprocating tachycardia and atrioventricular nodal tachycardia. The drug has no negative effect on the functional state of heart.
Chachua
T
T
Abuladze
G
G
Nebieridze
M
M
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D011405:Propafenone / Q000009:adverse effects / Q000627:therapeutic use*; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy* / Q000517:prevention & control; D013617:Tachycardia, Supraventricular / Q000188:drug therapy* / Q000517:prevention & control; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D011405:Propafenone